RXRX
Recursion Pharmaceuticals, Inc.
$3.01
$1.35B
Price
$3.01
Market Cap
$1.35B
Revenue CAGR (5Y)
+71.5%
EPS CAGR (5Y)
-15.1%
Revenue Growth
Year over Year+0.0%
2019
+99.5%
2020
+193.0%
2021
+296.8%
2022
+10.6%
2023
+34.1%
2024
+26.9%
2025
EPS Growth
Year over Year+0.0%
2019
-40.6%
2020
-100.1%
2021
-29.5%
2022
-16.2%
2023
-7.0%
2024
+14.8%
2025